Table 2.

Pathology and therapy for “bystander GVAX” subjects undergoing craniotomy for resection of recurrent malignant glioma

PatientExtent of resectionPathologyViable tumor cellsTumor cells/vaccinationVaccinations receivedInitial post-vaccination therapy
1SubtotalGlioblastoma7.9 × 1071.2 × 1076Bev/CPT-11
2SubtotalGlioblastoma1.9 × 1081.6 × 1075Bev/CPT-11
3SubtotalGlioblastoma2.0 × 1083.0 × 1074Bev
4Near totalGlioblastoma1.6 × 1082.5 × 1076Bev
5Near totalGlioblastoma3.0 × 1074.2 × 1065Bev/CPT-11
6Near totalGlioblastoma9.4 × 1071.4 × 1076Ang1005
7Gross totalRadiation NecrosisN/AN/A0
8Gross TotalGlioblastoma2.5 × 1088.2 × 1056None
9Gross TotalGlioblastoma5.8 × 1063.7 × 1076Unknown
10Near totalGlioblastoma2.5 × 1093.4 × 1075Sirolimus and Vandetanib
11Gross TotalGlioblastoma3.4 × 1074.80 × 1066Bev
  • Abbreviation: N/A, not applicable.